Airway management

Association between glucagon‐like peptide‐1 receptor agonist use and peri‐operative pulmonary aspiration: a systematic review and meta‐analysis

AnaesthesiaPublished Systematic review and meta-analysis of observational studies

Pooled result · Pulmonary aspirationResult — go to the resultOdds ratio 1.04 95% CI 0.87–1.25

Authors' conclusion

Patients using glucagon-like peptide-1 receptor agonists are at increased risk of presenting for anaesthesia with residual gastric contents, though the available evidence does not indicate that this translates to an increased risk of pulmonary aspiration.

Study context

Population
Fasted patients or volunteers undergoing procedures requiring anaesthesia or sedation28 observational studies
Comparison
GLP-1 receptor agonist exposure vs no exposure
Outcome
Peri-operative pulmonary aspiration
Methodological detailsrandom effects meta-analysis, GRADE certainty assessment, Six databases searched; 9010 studies screened
  • Random effects meta-analysis
  • GRADE certainty assessment
  • Six databases searched; 9010 studies screened

Pooled result

Pulmonary aspiration

Odds ratio

1.04

95% CI 0.87–1.25

GLP-1 receptor agonist vs No GLP-1 receptor agonist
OR 1.04 (95% CI 0.87–1.25)

As reported in the abstract

Further pooled results

OutcomeOR (95% CI)
Residual gastric contents despite appropriate fastingGLP-1 receptor agonist vs No GLP-1 receptor agonist · 18 studies, 165,522 patients, 3831 cases · low certainty of evidence5.96 (3.96–8.98)

Residual gastric contents: withholding ≥1 dose before procedure vs not withholding

OR (95% CI)
Withholding at least one dose5 studies, 1706 patients, 208 cases · very low certainty of evidence0.51 (0.33–0.81)

Original publication

Association between glucagon‐like peptide‐1 receptor agonist use and peri‐operative pulmonary aspiration: a systematic review and meta‐analysis. Anaesthesia. Published 15 April 2025. doi:10.1111/anae.16601

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.